{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:21:34Z","timestamp":1787163694944,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clgc.2025.102388","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:19:06Z","timestamp":1750209546000},"page":"102388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the Effects of Enzalutamide and Abiraterone Acetate on Sarcopenia in Metastatic Castration-Sensitive Prostate Cancer"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8604-9988","authenticated-orcid":false,"given":"Cevat \u0130lteri\u015f","family":"K\u0131k\u0131l\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maide","family":"M\u00fcreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Kapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-6393","authenticated-orcid":false,"given":"Bahad\u0131r","family":"K\u00f6yl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-1921","authenticated-orcid":false,"given":"Fatih","family":"Kemik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyyaz Hazar","family":"Ya\u011fmur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Sel\u00e7ukbiricik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"\u0130nci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-6469","authenticated-orcid":false,"given":"Deniz","family":"Tural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clgc.2025.102388_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11864-019-0668-8","article-title":"Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm","volume":"20","author":"Weiner","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102388_bib0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(23)00063-3","article-title":"Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Sweeney","year":"2023","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.clgc.2025.102388_bib0003","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102388_bib0004","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1470-2045(19)30082-8","article-title":"Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial","volume":"20","author":"Fizazi","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2025.102388_bib0005","article-title":"Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer","volume":"25","author":"Fischer","year":"2020","journal-title":"Cancer Treat Res Commun"},{"issue":"12","key":"10.1016\/j.clgc.2025.102388_bib0006","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102388_bib0007","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/jcsm.13629","article-title":"Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta-Analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.clgc.2025.102388_bib0008","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/jjco\/hyaa045","article-title":"Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer","volume":"50","author":"Ikeda","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"24","key":"10.1016\/j.clgc.2025.102388_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246345","article-title":"Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.clgc.2025.102388_bib0010","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.afos.2021.03.002","article-title":"Sarcopenia and mortality in cancer: A meta-analysis","volume":"7","author":"Au","year":"2021","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.clgc.2025.102388_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722652","article-title":"Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer","volume":"11","author":"Chiang","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102388_bib0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOU.0000000000000885","article-title":"The prognostic value of sarcopenia in patients with prostate cancer: a systematic review","volume":"31","author":"Jahrreiss","year":"2021","journal-title":"Curr Opin Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102388_bib0013","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.euo.2025.02.006","article-title":"Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation\u202f+\u202fEnzalutamide \u00b1 Zoledronic Acid. The BONENZA Study","volume":"8","author":"Buffoni","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102388_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.clgc.2025.102388_bib0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jcsm.12158","article-title":"A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients","volume":"8","author":"van Vugt","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"16","key":"10.1016\/j.clgc.2025.102388_bib0016","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.clgc.2025.102388_bib0017","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and Cardiovascular Diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clgc.2025.102388_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clgc.2025.102388_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/01635581.2024.2401648","article-title":"The Prevalence of Sarcopenia in Patients with Solid Tumors Differs Across Regions: A Systematic Review","volume":"77","author":"Thormann","year":"2025","journal-title":"Nutr Cancer"},{"issue":"26","key":"10.1016\/j.clgc.2025.102388_bib0020","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2011.38.8850","article-title":"Sarcopenia during androgen-deprivation therapy for prostate cancer","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102388_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071631","article-title":"Androgen Deprivation Therapy for Prostate Cancer Influences Body Composition Increasing Risk of Sarcopenia","volume":"15","author":"Korczak","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clgc.2025.102388_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2023.09.004","article-title":"Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy","volume":"57","author":"Blow","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"9768","key":"10.1016\/j.clgc.2025.102388_bib0023","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clgc.2025.102388_bib0024","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arr.2010.03.004","article-title":"Resistance exercise for muscular strength in older adults: a meta-analysis","volume":"9","author":"Peterson","year":"2010","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.clgc.2025.102388_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41391-022-00519-4","article-title":"A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)","volume":"25","author":"Harrison","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.clgc.2025.102388_bib0026","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/j.2040-4603.2012.tb00476.x","article-title":"Cancer, physical activity, and exercise","volume":"2","author":"Brown","year":"2012","journal-title":"Compr Physiol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:24:45Z","timestamp":1757517885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1558767325000886"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102388","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Effects of Enzalutamide and Abiraterone Acetate on Sarcopenia in Metastatic Castration-Sensitive Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102388"}}